Approval · Notice of Compliance 1226 · 2000
IMDUR: Notice of Compliance 1226
Issued April 20, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1226
- Date
- April 20, 2000
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antianginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IMDUR | 02126559 | Dormant |
Medicinal ingredients
- ISOSORBIDE-5-MONONITRATE 60 MG per TAB